TrialJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2014

Recombinant human interleukin-1 receptor antagonist in severe traumatic brain injury: a phase II randomized control trial.

Adel Helmy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.